Efficacy and safety of the mono-and combined therapy with oxcarbazepine in adult patients

Zhurnal Nevrologii i Psihiatrii imeni S.S. Korsakova

Volumn 110, Issue 6, 2010, Pages 66-69

  Burd, S G ^a   Glukhova, L Yu ^a   Badalyan, O L ^a  

^a NONE

Author keywords

Adverse effects; Epilepsy; Oxcarbazepine; Treatment; Trileptal

Indexed keywords

OXCARBAZEPINE;

ADULT; AGED; ARTICLE; CLINICAL ASSESSMENT; CLINICAL TRIAL; CONSCIOUSNESS; CONSCIOUSNESS LEVEL; DISEASE DURATION; DIZZINESS; DRUG DOSE TITRATION; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; FOCAL EPILEPSY; GENERALIZED EPILEPSY; HUMAN; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; RECOMMENDED DRUG DOSE; RUSSIAN FEDERATION; SEIZURE; SOMNOLENCE; TITRIMETRY; TREATMENT DURATION; TREATMENT RESPONSE;

EID: 78650653047     PISSN: 19977298     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Albani F, Baruzzi A. PRIMO Study Group. Oxcarbazepine long-term treatment retention in patients switched over from carbamazepine. Neurol Sci 2006 Jul; 27:3: 173-175.
2. Beydoun A., Sachdeo R. C., Kutluay E. et al. Sustained efficacy and longterm safety of oxcarbazepine: one-year open-label extension of a study in refractory partial epilepsy. Epilepsia 2003;44:9: 1160-1165.
3. Dogan E. A., Usta B. E., Bilgen R. et al. Efficacy, tolerability, and side effects of oxcarbazepine monotherapy: a prospective study in adult and elderly patients with newly diagnosed partial epilepsy. Epilep Behav 2008 Jul; 13:1: 156-161.
4. Franzoni E., Gentile V., Pellicciari A. et al. Prospective study on long-term treatment with oxcarbazepine in pediatric epilepsy. J Neurol 2009 Sep; 256:9: 1527-1532.
5. Freidel M., Krause E., Kuhn K. et al. Multizentrische Anwendungsbeobachtung mit 1385 Epilepsie-Patienten zur Neueinstellung oder Umstellung auf Oxcarbazepin. Fortschr Neurol Psychiat 2007;75:2: 100-106.
6. Glauser T. A. Oxcarbazepine in the treatment of epilepsy. Pharmacotherapy 2001 Aug; 21:8: 904-919
7. Hamdy N. A., Ginby D., Feltbower R., Ferrie CD. Ethnic differences in the incidence of seizure disorders in children from Bradford, United kingdom. Epilepsia 2007 May; 48:5: 913-916.
8. Kothare S. V., Khurana D. S., Mostofi N. Oxcarbazepine monotherapy in children and adolescents: a single-center clinical experience. Pediat Neurol 2006 Oct; 35:4: 235-239. (Pubitemid 44397424)
9. Lloyd P., Flesch G., Dieterle W. Clinical pharmacology and pharmacokinetics of oxcarbazepine. Epilepsia 1994;35(Suppl 3): S10-13.
10. Martinez W., Ingenito A., Blakeslee M. et al. Efficacy, safety, and tolerability of oxcarbazepine monotherapy. J Epilep Behav 2006 Nov; 9:3: 448-456.
11. Maschio M., Dinapoli L., Vidiri A. et al. The role side effects play in the choice of antiepileptic therapy in brain tumor-related epilepsy: a comparative study on traditional antiepileptic drugs versus oxcarbazepine. J Exp Clin Cancer Res 2009 May 6; 28:60.
12. May T. W., Korn-Merker E., Rambeck B. Clinical pharmacokinetics of oxcarbazepine. Clin Pharmacokinet 2003;42:12: 1023-1042.
13. McLean M. J., Schmutz M., Wamil A. W. et al. Oxcarbazepine: mechanisms of action. Epilepsia 1994;35(Suppl 3): S5-9.
14. th ed. Philadelphia: Lipincott Williams & Wilkins 2001;451-458.
15. Neels H. M., Sierens A. C, Naelaerts K. et al. Therapeutic drug monitoring of old and newer anti-epileptic drugs. Clin Chem Lab Med 2004;42:11: 1228-1255.
16. Perucca E. Clinically relevant drug interactions with antiepileptic drugs. Br J Clin Pharmacol 2006 Mar; 61:3: 246-255.
17. Rabasseda X. Oxcarbapezine: anticonvulsant profile and safety. Drugs Today (Barc) 2001 May; 37:5: 333-355.
18. Sachdeo R. C., Gates J. R., Bazil C. W. Improved quality of life in patients with partial seizures after conversion to oxcarbazepine monotherapy. Epilep Behav 2006 Nov; 9:3: 457-463.
19. Schachter S. C., Vazquez B., Fisher R. S. Oxcarbazepine: double-blind, randomized, placebo-control, monotherapy trial for partial seizures. Neurology 1999 Mar. 10; 52:4: 732-737.
20. Schmidt D., Sachdeo R. Oxcarbazepine for Treatment of Partial Epilepsy: A Review and Recommendations for Clinical Use. Epilep Behav 2000 Dec; 1:6: 396-405.